Back to TXG

CITADEL ADVISORS LLC → TXG

CITADEL ADVISORS LLC TXG Position History

10x Genomics, Inc.

Quarters held
11
Latest value
$1.4M
Q2 2026
Peak value
$106.6M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$15.8M
Q1 2026$3.7M
Q1 2026$282K
Q2 2026$106.6M
Q2 2026$5.8M
Q2 2026$3K
Q2 2026$1.4M
Q2 2026$106.6M
Q2 2026$5.8M
Q2 2026$3K
Q2 2026$1.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$1.4M36.9K——
Q2 2026$3K83——
Q2 2026$5.8M150.2K——
Q2 2026$106.6M2.78M——
Q2 2026$1.4M36.9K——
Q2 2026$3K83——
Q2 2026$5.8M150.2K——
Q2 2026$106.6M2.78M——
Q1 2026$282K13.3K——
Q1 2026$3.7M174.7K——
Q1 2026$15.8M743.7K——

Other funds holding TXG

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
SPY

SPDR S&P 500 ETF TR

$3B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
NVDA

NVIDIA CORPORATION

$2.1B
SPY

SPDR S&P 500 ETF TR

$2.1B
NVDA

NVIDIA CORPORATION

$2.1B